In Plain English:
Cortagen is a four-amino-acid chain (Ala-Glu-Asp-Pro) derived by directed synthesis from Cortexin, a polypeptide extract of bovine/porcine cerebral cortex tissue. In the same way Epithalon was distilled from pineal extract, Cortagen represents the defined synthetic core of the brain-cortex bioregulator family. Animal studies show it speeds sciatic nerve regrowth after injury (27% faster fibre growth, 40% better conduction velocity) and limits oxidative damage during chronic brain ischaemia. Cell studies demonstrate it enters nuclei and unrolls densely packed 'old' chromatin in lymphocytes from elderly donors, reactivating silenced ribosomal genes. No peer-reviewed human clinical trial has been completed; all efficacy data comes from Russian and Georgian lab groups without independent replication.
Research Maturity
Preclinical (~9–12 peer-reviewed papers (2000–2023); no independent replication; 0 human trials+ Studies)
Focus
Cognition
Neuroprotection
Stress Response
Origin
Synthesised by V.K. Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology via directed amino-acid synthesis based on compositional analysis of Cortexin (bovine cerebral cortex polypeptide fraction). First published sciatic-nerve data appeared in 2000 (PMID 11276314). Structurally differs from Epithalon (AEDG) by a single C-terminal substitution: Gly → Pro.
Mechanism
Penetrates cell nuclei and binds specific DNA sequence motifs (ATTTG/ATTTC, methylated cytosine residues) to induce deheterochromatinisation — decondensation of total heterochromatin and facultative heterochromatin — reactivating silenced ribosomal RNA gene clusters on acrocentric chromosome stalks (chromosomes 13, 14, 15, 21, 22). Upregulates IL-2 mRNA in splenocytes and hypothalamic cells in a concentration- and time-dependent manner. Microarray analysis of cardiac tissue after 5-day dosing identified expression changes in 110 genes spanning signal transduction, oxidative stress response, and tissue-repair pathways, indicating upstream chromatin-level rather than single-pathway modulation. In ischaemia models, limits lipid peroxidation and preserves antioxidant activity in brain tissue.
Outcome
Sciatic nerve fibre growth rate (+27%, rat transsection/suture model, IM 10 µg/kg × 10 days, PMID 11276314); nerve conduction velocity (+40%, same model); cardiac gene expression (234 clones with significant change across 110 known genes by microarray, PMID 15159690); chromatin decondensation in lymphocytes from 75–88-year-old donors (PMID 15085253, 33526740, 37042594); IL-2 mRNA upregulation in splenocytes in vitro (PMID 12447482) and hypothalamic nuclei in vivo (PMID 16224591); lipid peroxidation inhibition and antioxidant preservation in chronic ischaemia rat model (PMID 21476278).
